UCSF

ZINC19796158

Substance Information

In ZINC since Heavy atoms Benign functionality
November 10th, 2008 23 Yes

Other Names:

pin(e)

1977-10-2

1977-10-2; Adasuve (TN); D02340; Loxapine (USAN/INN)

1977-10-2; C07104; Loxapine

2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine

2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine; 2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine; BRN 0626753; C18H18ClN3O; CL 62362; CL-62362; CL-71,563; Cloxazepine

2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine

2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine monohydrochloride; Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-, monohydrochloride; LS-186470; Loxapine hydrochloride

2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1)

2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1); Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine (1:1); C18H18ClN3O; CCRIS 1917; CL 71563; Cloxazepin; Daxolin; EINECS 248-682-0; LOX

2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine

2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine

27833-64-3 (succinate)

27833-64-3; D00794; Loxapine succinate (USP); Loxitane (TN)

27833-64-3; Loxapine succinate; Prestwick_304

54810-23-0 (mono-hydrochloride)

54810-23-0; D08148; Desconex (TN); Loxapine hydrochloride

8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine

8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine

AC1L1H3Z

AC1Q3ZWR

Adasuve

AZ-004

AZ-104

BPBio1_000226

BRD-K39915878-036-04-6

BRD-K39915878-036-05-3

BRN 0626753

BSPBio_000204

BSPBio_003479

C07104

C18H18ClN3O

CHEBI:50839; CHEBI:6548

CHEBI:50841

CHEMBL831

CID3964

CL 62362

CL-62362

CL-62362; SUM 3170; SUM-3170; CL-71563

CL-71,563

CL-71563

Cloxazepine

CPD000058470

CPD000058470; LOXAPINE SUCCINATE; SAM001247061

CPD000058470; Loxapine; Loxapine succinate; SAM001247061

D02340

DAP000311

DB00408

Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-

Dibenzacepin

Dibenzoazepine

Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-

DivK1c_006919

EINECS 217-835-3

FDA

HF 3170

HF3170

HSDB 3111

Hydrofluoride 3170

INN

KBio1_001863

KBio2_000835

KBio2_003403

KBio2_005971

KBio3_002983

KBioSS_000835

L001085

Lossapina

Lossapina [Dcit]

Loxapac

Loxapin

Loxapina

Loxapina [INN-Spanish]

Loxapine

Loxapine (BAN

Loxapine (USAN/INN)

Loxapine Hydrochloride (FDA); Loxapine (BAN

Loxapine succinate salt

Loxapine [Usan:Ban:Inn]

Loxapine [USAN:INN:BAN]

Loxapinesuccinatesalt

Loxapinsuccinate

Loxapinum

Loxapinum [INN-Latin]

Loxepine

Loxitane

Loxitane C

Loxitane Im

LS-61562

LW 3170

MFCD00069298

MolPort-002-885-838

N/A

NCGC00021145-01

NCGC00021145-07

NCGC00022279-03

NCGC00022279-04

NCGC00022279-05

Oxilapine

PDSP1_001058

PDSP2_001042

Prestwick0_000132

Prestwick1_000132

Prestwick2_000132

Prestwick3_000132

QTL1_000050

S 805

S-805

SPBio_001814

SPBio_002143

SpecPlus_000823

Spectrum2_001737

Spectrum3_001830

Spectrum5_001857

Spectrum_000355

Staccato-loxapine

SUM 3170

SUM-3170

UNII-LER583670J

USAN

USAN)

USAN); Loxapine HCl (FDA); Loxapine Succinate (FDA

USAN); Loxapine Succinate (FDA

USP

USP)

ZINC19796158

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.25 7.92 -8.16 0 4 0 33 327.815 1

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.03e-01 g/l DrugBank-approved
Target 5-HT Receptor,Dopamine Receptor Selleck Chemicals
therap antipsychotic MicroSource Spectrum
Indications anxiolytic, antipsychotic, schizophrenia KeyOrganics Bioactives
Therapy Dibenzoxazepine antipsychotic agent SMDC MicroSource
Patent Database Links EP1181933; EP1627639; EP1844769; EP1990046; US2004142904; US2005009870; US2005014786; US2005080087; US2006166974; US2006199798; US2007207222; US2007208004; US2007232691; US2007238725; US2007259952; US2007270403; WO2005007628; WO2005016286; WO2005037199; W ChEBI
Patent Database Links EP1627639; EP1829534; US2007185018; US2007212428; US2008221078; WO2007112581 ChEBI
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 100738; 1 succinic acid NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 100738; SALT: 1 succinic acid NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
5HT2A-1-E Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 6 0.50 Binding ≤ 10μM
5HT2C-1-E Serotonin 2c (5-HT2c) Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 1000 0.37 Binding ≤ 10μM
5HT6R-2-E Serotonin 6 (5-HT6) Receptor (cluster #2 Of 2), Eukaryotic Eukaryotes 50 0.44 Binding ≤ 10μM
5HT7R-2-E Serotonin 7 (5-HT7) Receptor (cluster #2 Of 3), Eukaryotic Eukaryotes 43 0.45 Binding ≤ 10μM
ACM1-1-E Muscarinic Acetylcholine Receptor M1 (cluster #1 Of 5), Eukaryotic Eukaryotes 5500 0.32 Binding ≤ 10μM
DRD3-1-E Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 22 0.47 Binding ≤ 10μM
DRD4-2-E Dopamine D4 Receptor (cluster #2 Of 4), Eukaryotic Eukaryotes 5 0.51 Binding ≤ 10μM
HRH1-1-E Histamine H1 Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 1000 0.37 Binding ≤ 10μM
DRD2-15-E Dopamine D2 Receptor (cluster #15 Of 24), Eukaryotic Eukaryotes 21 0.47 Binding ≤ 10μM
Z104304-1-O Adrenergic Receptor Alpha-1 (cluster #1 Of 3), Other Other 18 0.47 Binding ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 5012 0.32 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
Z104304 Z104304 Adrenergic Receptor Alpha-1 18 0.47 Binding ≤ 1μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 21 0.47 Binding ≤ 1μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 21 0.47 Binding ≤ 1μM
DRD3_HUMAN P35462 Dopamine D3 Receptor, Human 22 0.47 Binding ≤ 1μM
DRD4_HUMAN P21917 Dopamine D4 Receptor, Human 14 0.48 Binding ≤ 1μM
HRH1_RAT P31390 Histamine H1 Receptor, Rat 1000 0.37 Binding ≤ 1μM
5HT2A_RAT P14842 Serotonin 2a (5-HT2a) Receptor, Rat 6 0.50 Binding ≤ 1μM
5HT2C_RAT P08909 Serotonin 2c (5-HT2c) Receptor, Rat 1000 0.37 Binding ≤ 1μM
5HT6R_HUMAN P50406 Serotonin 6 (5-HT6) Receptor, Human 15 0.48 Binding ≤ 1μM
5HT7R_RAT P32305 Serotonin 7 (5-HT7) Receptor, Rat 43 0.45 Binding ≤ 1μM
Z104304 Z104304 Adrenergic Receptor Alpha-1 18 0.47 Binding ≤ 10μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 21 0.47 Binding ≤ 10μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 21 0.47 Binding ≤ 10μM
DRD3_HUMAN P35462 Dopamine D3 Receptor, Human 22 0.47 Binding ≤ 10μM
DRD4_HUMAN P21917 Dopamine D4 Receptor, Human 14 0.48 Binding ≤ 10μM
HRH1_RAT P31390 Histamine H1 Receptor, Rat 1000 0.37 Binding ≤ 10μM
ACM1_HUMAN P11229 Muscarinic Acetylcholine Receptor M1, Human 5500 0.32 Binding ≤ 10μM
5HT2A_RAT P14842 Serotonin 2a (5-HT2a) Receptor, Rat 6 0.50 Binding ≤ 10μM
5HT2C_RAT P08909 Serotonin 2c (5-HT2c) Receptor, Rat 1000 0.37 Binding ≤ 10μM
5HT6R_HUMAN P50406 Serotonin 6 (5-HT6) Receptor, Human 15 0.48 Binding ≤ 10μM
5HT7R_RAT P32305 Serotonin 7 (5-HT7) Receptor, Rat 43 0.45 Binding ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 5011.87234 0.32 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Dopamine receptors
G alpha (i) signalling events
G alpha (q) signalling events
G alpha (s) signalling events
Muscarinic acetylcholine receptors
Serotonin receptors

Analogs ( Draw Identity 99% 90% 80% 70% )